PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.
Also called NCT03225001
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 197 participants
- Sponsor
- Registry
-
NCT03225001
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03225001. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06-11 (actual); primary completion 2016-12-16 (actual). Results posted on 2018-01-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve
- Acronym
- PII NR3/ViV
- Condition
- Aortic Stenosis
- Condition
- Cardiomyopathy, Hypertrophic
- Intervention (Device)
- Edwards SAPIEN XT transcatheter valve, Model 9300TFX
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct03225001- Content hash
cf08f9fb90ac07af45ed214c595648f6cdd60076fd6eb66655292bb0d7c48675